Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea · Delayed Price · Currency is KRW 10,720
-90 (-0.83%)
Apr 30, 2026, 3:30 PM KST
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 229.77 billion as of April 30, 2026. Its market cap has decreased by -20.00% in one year.
Market Cap
229.77B
Enterprise Value
363.99B
Revenue
605.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,720.00
Market Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 229.77B, an increase of 1,172.24%. That is a compound annual growth rate of 10.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 229.77B | -10.29% |
| Dec 30, 2025 | 256.13B | -16.14% |
| Dec 30, 2024 | 305.43B | -7.98% |
| Dec 28, 2023 | 331.93B | -15.58% |
| Dec 29, 2022 | 393.20B | 14.64% |
| Dec 30, 2021 | 343.00B | -9.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Pharmaceutical | 248.55B |
| Hyundai Pharmaceutical | 246.61B |
| Boditech Med | 239.66B |
| Chong Kun Dang Holdings | 237.31B |
| AptaBio Therapeutics | 233.74B |
| Samjin Pharmaceuticals | 232.78B |
| Suheung | 226.06B |
| Whan In Pharm | 217.74B |